140 related articles for article (PubMed ID: 20615891)
21. Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis.
Khan MH; Khalil A; Rashid H
Genet Res (Camb); 2015 Apr; 97():e7. PubMed ID: 25882871
[TBL] [Abstract][Full Text] [Related]
22. Association between p53 Arg72Pro polymorphism and colorectal cancer risk: a meta-analysis.
Economopoulos KP; Sergentanis TN; Zagouri F; Zografos GC
Onkologie; 2010; 33(12):666-74. PubMed ID: 21124037
[TBL] [Abstract][Full Text] [Related]
23. Association of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis.
Tang W; Zhou X; Nie S; Yang Z; Zhu H; Wu X; Zhao R; Luo Y
Biomarkers; 2012 Nov; 17(7):597-603. PubMed ID: 22780299
[TBL] [Abstract][Full Text] [Related]
24. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
25. Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.
Xiang B; Mi YY; Li TF; Liu PF
Asian Pac J Cancer Prev; 2012; 13(5):1787-91. PubMed ID: 22901123
[TBL] [Abstract][Full Text] [Related]
26. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
[TBL] [Abstract][Full Text] [Related]
27. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
Ye J; Li XF; Wang YD; Yuan Y
PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330
[TBL] [Abstract][Full Text] [Related]
28. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.
Sameer AS; Shah ZA; Syeed N; Banday MZ; Bashir SM; Bhat BA; Siddiqi MA
Genet Mol Res; 2010 Apr; 9(2):651-60. PubMed ID: 20449797
[TBL] [Abstract][Full Text] [Related]
29. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
[TBL] [Abstract][Full Text] [Related]
30. TP53 Gene Pro72Arg (rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population.
Asadi M; Shanehbandi D; Zarintan A; Pedram N; Baradaran B; Zafari V; Shirmohamadi M; Hashemzadeh S
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3423-3427. PubMed ID: 29286614
[TBL] [Abstract][Full Text] [Related]
31. Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma.
Zhang JN; Yi SH; Zhang XH; Liu XY; Mao Q; Li SQ; Xiong WH; Qiu YM; Chen T; Ge JW
Genet Mol Res; 2012 Oct; 11(4):3618-28. PubMed ID: 23096687
[TBL] [Abstract][Full Text] [Related]
32. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer.
Koushik A; Tranah GJ; Ma J; Stampfer MJ; Sesso HD; Fuchs CS; Giovannucci EL; Hunter DJ
Int J Cancer; 2006 Oct; 119(8):1863-8. PubMed ID: 16721787
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
34. TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis.
Jiang DK; Wang WZ; Ren WH; Yao L; Peng B; Yu L
J Invest Dermatol; 2011 Jan; 131(1):220-8. PubMed ID: 20861852
[TBL] [Abstract][Full Text] [Related]
35. TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case-control study.
Fang Y; Wu X; Li L; Zhu J; Wu H; Zhou H; He J; Wang Y
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406493
[TBL] [Abstract][Full Text] [Related]
36.
Liu P; Zhuo Z; Li W; Cheng J; Zhou H; He J; Zhang J; Wang J
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610160
[TBL] [Abstract][Full Text] [Related]
37. TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis.
Yan L; Zhang D; Chen C; Mao Y; Xie Y; Li Y; Huang Y; Han B
Int J Cancer; 2009 Dec; 125(12):2903-11. PubMed ID: 19623649
[TBL] [Abstract][Full Text] [Related]
38. Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.
Dahabreh IJ; Murray S
Cancer Epidemiol; 2011 Dec; 35(6):503-9. PubMed ID: 21474413
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies.
Ren WH; Jiang DK; Pei Y; Wang SQ; Yang XM; Yu L
Genet Mol Res; 2014 Jan; 13(1):103-14. PubMed ID: 24446292
[TBL] [Abstract][Full Text] [Related]
40. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
